NCT05259553View on ClinicalTrials.gov

Biomarkers in Multiple Myeloma

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 20, 2022

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2027

Conditions
Hematological PatientsNewly Diagnosed Multiple MyelomaChemotherapy
Interventions
OTHER

Blood samples

"Peripheral blood sampling will be performed at different time points of the study, for a total volume of 20-40 mL:~* Sampling before MM treatment,~* Sampling during MM treatment (at 3 months post-initiation if no autograft or before autograft),~* Only for Patients treated with Apixaban or Eliquis®, 2 additional samplings during MM treatment for pharmacokinetics analysis."

Trial Locations (2)

42055

RECRUITING

CHU de Saint-Etienne, Saint-Etienne

69495

RECRUITING

Hospices Civils de Lyon, Lyon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Saint Etienne

OTHER